Logo GENinCode

Contact information

Joan Puig, CEO GENinCode SLU ; Marie Laurent, Marketing and Market Acces Director
Rba d’Egara 235, 5 08224 Terrassa (Barcelona), Spain
Balmes 177, 1º 2ª 08006 Barcelona, Spain
+34 647 46 80 94 // +34 622 13 53 77
Areas of activities
  • Areas of activity
    • In vitro diagnostics
  • Therapeutic areas
    • Cardiovascular diseases and circulatory system
    • Genetic and rare diseases
    • Gynaecology and obstetrics

GENinCode specializes in risk assessment and prediction of cardiovascular disease thrombosis and familial hypercholesterolemia. We are passionate about the genetics revolution in personalized medicine. We are committed to driving and supporting the incorporation of genetics in daily medical practice, through cooperation with health care professionals to improve the management of patients’ health in the areas of prevention, diagnosis, and treatment.

Products and services
  • LIPID inCode®: Genetic diagnostic test of Familial Hypercholesterolemia and cardiovascular risk stratification
  • CARDIO inCode®: Diagnosis and clinical management of the coronary genetic risk
  • THROMBO inCode®: Diagnosis of hereditary thrombophilia and clinical management of thrombosis risk
  • THROMBO inCode® Reproductive Health: Evaluation of the impact of hereditary thrombophilia on Reproductive Health
  • THROMBO inCode® Oncology: Risk assessment of thrombosis in Oncology patients 
  • SUDD inCode®: Diagnosis of Familial Cardiomyopathies and related Cardiac sudden death
Areas of interest for future collaborations

Primary Cardiovascular Prevention, Secondary Cardiovascular Prevention, Dislipemia including Familial Hypercholesterolemia, Thromboprophylaxis specially in Oncology.